Show simple item record

dc.contributor.authorSmith, Gaynor A.en_US
dc.contributor.authorRocha, Emily M.en_US
dc.contributor.authorRooney, Thomasen_US
dc.contributor.authorBarneoud, Pascalen_US
dc.contributor.authorMcLean, Jesse R.en_US
dc.contributor.authorBeagan, Jonathanen_US
dc.contributor.authorOsborn, Teresiaen_US
dc.contributor.authorCoimbra, Madeleineen_US
dc.contributor.authorLuo, Yongyien_US
dc.contributor.authorHallett, Penelope J.en_US
dc.contributor.authorIsacson, Oleen_US
dc.date.accessioned2015-05-04T15:27:19Z
dc.date.issued2015en_US
dc.identifier.citationSmith, G. A., E. M. Rocha, T. Rooney, P. Barneoud, J. R. McLean, J. Beagan, T. Osborn, et al. 2015. “A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C).” PLoS ONE 10 (3): e0121072. doi:10.1371/journal.pone.0121072. http://dx.doi.org/10.1371/journal.pone.0121072.en
dc.identifier.issn1932-6203en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:15034914
dc.description.abstractDopaminergic neurons in the substantia nigra pars compacta (SNpc) are characterized by the expression of genes required for dopamine synthesis, handling and reuptake and the expression of these genes is largely controlled by nuclear receptor related 1 (Nurr1). Nurr1 is also expressed in astrocytes and microglia where it functions to mitigate the release of proinflammatory cytokines and neurotoxic factors. Given that Parkinson’s disease (PD) pathogenesis has been linked to both loss of Nurr1 expression in the SNpc and inflammation, increasing levels of Nurr1 maybe a promising therapeutic strategy. In this study a novel Nurr1 agonist, SA00025, was tested for both its efficiency to induce the transcription of dopaminergic target genes in vivo and prevent dopaminergic neuron degeneration in an inflammation exacerbated 6-OHDA-lesion model of PD. SA00025 (30mg/kg p.o.) entered the brain and modulated the expression of the dopaminergic phenotype genes TH, VMAT, DAT, AADC and the GDNF receptor gene c-Ret in the SN of naive rats. Daily gavage treatment with SA00025 (30mg/kg) for 32 days also induced partial neuroprotection of dopaminergic neurons and fibers in rats administered a priming injection of polyinosinic-polycytidylic acid (poly(I:C) and subsequent injection of 6-OHDA. The neuroprotective effects of SA00025 in this dopamine neuron degeneration model were associated with changes in microglial morphology indicative of a resting state and a decrease in microglial specific IBA-1 staining intensity in the SNpc. Astrocyte specific GFAP staining intensity and IL-6 levels were also reduced. We conclude that Nurr1 agonist treatment causes neuroprotective and anti-inflammatory effects in an inflammation exacerbated 6-OHDA lesion model of PD.en
dc.language.isoen_USen
dc.publisherPublic Library of Scienceen
dc.relation.isversionofdoi:10.1371/journal.pone.0121072en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376720/pdf/en
dash.licenseLAAen_US
dc.titleA Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)en
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalPLoS ONEen
dash.depositing.authorMcLean, Jesse R.en_US
dc.date.available2015-05-04T15:27:19Z
dc.identifier.doi10.1371/journal.pone.0121072*
dash.authorsorderedfalse
dash.contributor.affiliatedMcLean, Jesse R.
dash.contributor.affiliatedHallett, Penelope
dash.contributor.affiliatedOsborn, Teresia
dash.contributor.affiliatedIsacson, Ole


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record